ETVAX Trademark

Trademark Overview

On Wednesday, December 29, 2021, a trademark application was filed for ETVAX with the United States Patent and Trademark Office. The USPTO has given the ETVAX trademark a serial number of 97194575. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, July 1, 2024. This trademark is owned by SCANDINAVIAN BIOPHARMA HOLDING AB. The ETVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
etvax

General Information

Serial Number97194575
Word MarkETVAX
Filing DateWednesday, December 29, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, July 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSCANDINAVIAN BIOPHARMA HOLDING AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOLNA 17148
SE
Party NameSCANDINAVIAN BIOPHARMA HOLDING AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOLNA 17148
SE

Trademark Events

Event DateEvent Description
Saturday, January 1, 2022NEW APPLICATION ENTERED
Wednesday, January 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 3, 2022ASSIGNED TO EXAMINER
Monday, October 3, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, October 3, 2022EXAMINERS AMENDMENT E-MAILED
Monday, October 3, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 3, 2022EXAMINER'S AMENDMENT ENTERED
Monday, October 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 22, 2023SOU EXTENSION 1 FILED
Wednesday, February 22, 2023SOU EXTENSION 1 GRANTED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 28, 2023SOU EXTENSION 2 FILED
Tuesday, November 28, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2024SOU EXTENSION 3 GRANTED
Monday, July 1, 2024SOU EXTENSION 3 FILED
Monday, July 1, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

etvax human vaccines